The small print

1. Results are based on the SURMOUNT-1 Mounjaro trial. Results vary – weight loss can be more or less than the 21% average.

Jastreboff, A.M. et al. (2022) "Tirzepatide Once Weekly for the Treatment of Obesity" New England Journal of Medicine, 387(3)

https://doi.org/10.1056/NEJMoa2206038

2. West, S. et al. (2026) "Weight regain after cessation of medication for weight management: systematic review and meta-analysis" BMJ, 392:e085304

https://doi.org/10.1136/bmj-2025-085304



* Price may increase or decrease subject to market conditions.

** Coming soon.

*** An admin fee may apply for early cancellation. See our terms and conditions.

**** Terms and conditions apply.

***** Maximum of one consultation per week with no carry-over of unused appointments.